{
    "info": {
        "nct_id": "NCT04239157",
        "official_title": "A Phase II, Open-Label, Study of Subcutaneous Canakinumab, an Anti-IL-1β Human Monoclonal Antibody, for Patients With Low or Int-1 Risk IPSS/IPSS-R Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia",
        "inclusion_criteria": "* Age ≥ 18 years as MDS and CCUS are very rare conditions in the pediatric setting.\n* Cohorts 1-3: Diagnosis of MDS according to WHO 2016 classification and low or intermediate-1 risk by IPSS or IPSS-R with a score of ≤ 3.5.\n* Cohort 4: Diagnosis of CCUS defined as:\n* Presence of a somatic pathogenic variant associated with hematological malignancy without morphological evidence of myelodysplasia\n* Variant allele fraction of greater than or equal to 2% in at least one identified somatic pathogenic variant\n* Bone marrow aspirate excluding hematological malignancy and MDS\n\n  * Presence of a cytopenia for >30 days. Cytopenia will be defined using accepted CHRS (Clonal Hematopoiesis Risk Score) criteria (Weeks et al, NEJM Evidence in press): ANC <1.8 or hgb <12 in females and <13 in males or a platelet count of <150.\n* Cohort 1: Participants need to have not responded to prior therapy with ESAs or hypomethylating agents (HMAs). These could include azacitidine, decitabine, SGI-110, ASTX727, or CC-486. Patients will need to have received at least 4 cycles of HMA. Participants with relapse or progression after any number of cycles of HMA by IWG 2006 criteria will also be candidates. Participants with evidence of del 5q alteration also are required to have been treated with Lenalidomide.\n* Cohort 1: Hemoglobin <10g/dL with symptomatic anemia or transfusion dependency defined as the need for prior transfusion in the past 8 weeks for a hemoglobin level less than 8g/dl.\n* Cohort 2: Transfusion dependency defined as the need for prior transfusion in the past 8 weeks of (1) at least 2 units of PRBC for a hemoglobin level less than 8g/dl or symptomatic anemia (hemoglobin <10g/dL), or (2) any platelet transfusion.\n* Participants (or patient's legally authorized representative) must have signed an informed consent document indicating that the patient understands the purpose of and procedures required for the study and is willing to participate in the study.\n* Adequate hepatic function with total bilirubin </=3 x ULN, AST or ALT </= 3xULN.\n* Serum creatinine clearance >30mL/min and no end/stage renal disease (using Cockcroft-Gault).\n* ECOG performance status </=2.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Active infection not adequately responding to appropriate antibiotics.\n* Prior treatment with IL-1/IL-1r inhibitors\n* Absolute neutrophil count (ANC) <0.5x109 k/ul; colony-stimulating factors can be administered prior to study drug initiation.\n* Female participants who are pregnant or lactating.\n* Participants with reproductive potential who are unwilling to following contraception requirements (including condom use for males with sexual partners, and for females: prescription oral contraceptives [birth control pills], contraceptive injections, intrauterine devices [IUD], double-barrier method [spermicidal jelly or foam with condoms or diaphragm], contraceptive patch, or surgical sterilization) throughout the study. Reproductive potential is defined as no previous surgical sterilization or females that are not post-menopausal for 12 months.\n* Female participants with reproductive potential who do not have a negative urine or blood beta-human chorionic gonadotropin (beta HCG) pregnancy test at screening.\n* History of an active malignancy within the past 2 years prior to study entry, with the exception of: a. Adequately treated in situ carcinoma of the cervix uteri b. Adequately treated basal cell carcinoma or localized squamous cell carcinoma of the skin or any other malignancy with a life expectancy of more than 2 years.\n* Participants receiving any other concurrent investigational agent or chemotherapy, radiotherapy, or immunotherapy (within 14 days of initiating study treatment).\n* Known history of testing positive for Human Immunodeficiency Virus (HIV) infections.\n\nParticipants requiring systemic steroids, methotrexate or other immunosuppressive drugs will not be included in the study.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "identified_line": {
                "line": "* Serum creatinine clearance >30mL/min and no end/stage renal disease (using Cockcroft-Gault).",
                "criterions": [
                    {
                        "exact_snippets": "Serum creatinine clearance >30mL/min",
                        "criterion": "serum creatinine clearance",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 30,
                                "unit": "mL/min"
                            }
                        }
                    },
                    {
                        "exact_snippets": "no end/stage renal disease",
                        "criterion": "end stage renal disease",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Serum creatinine clearance >30mL/min",
                        "criterion": "serum creatinine clearance",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 30,
                                "unit": "mL/min"
                            }
                        }
                    },
                    {
                        "exact_snippets": "no end/stage renal disease",
                        "criterion": "end stage renal disease",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Bone marrow aspirate excluding hematological malignancy and MDS",
                "criterions": [
                    {
                        "exact_snippets": "Bone marrow aspirate",
                        "criterion": "bone marrow aspirate",
                        "requirement": {
                            "requirement_type": "availability",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "excluding hematological malignancy and MDS",
                        "criterion": "hematological malignancy",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "excluding hematological malignancy and MDS",
                        "criterion": "myelodysplastic syndrome (MDS)",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Bone marrow aspirate",
                        "criterion": "bone marrow aspirate",
                        "requirement": {
                            "requirement_type": "availability",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "excluding hematological malignancy and MDS",
                        "criterion": "hematological malignancy",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "excluding hematological malignancy and MDS",
                        "criterion": "myelodysplastic syndrome (MDS)",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Adequate hepatic function with total bilirubin </=3 x ULN, AST or ALT </= 3xULN.",
                "criterions": [
                    {
                        "exact_snippets": "Adequate hepatic function with total bilirubin </=3 x ULN",
                        "criterion": "total bilirubin",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "x ULN"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Adequate hepatic function with ... AST or ALT </= 3xULN",
                        "criterion": "AST",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "x ULN"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Adequate hepatic function with ... AST or ALT </= 3xULN",
                        "criterion": "ALT",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "x ULN"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Adequate hepatic function with total bilirubin </=3 x ULN",
                                "criterion": "total bilirubin",
                                "requirement": {
                                    "requirement_type": "quantity",
                                    "expected_value": {
                                        "operator": "<=",
                                        "value": 3,
                                        "unit": "x ULN"
                                    }
                                }
                            }
                        ]
                    },
                    {
                        "or_criteria": [
                            {
                                "exact_snippets": "Adequate hepatic function with ... AST or ALT </= 3xULN",
                                "criterion": "AST",
                                "requirement": {
                                    "requirement_type": "quantity",
                                    "expected_value": {
                                        "operator": "<=",
                                        "value": 3,
                                        "unit": "x ULN"
                                    }
                                }
                            },
                            {
                                "exact_snippets": "Adequate hepatic function with ... AST or ALT </= 3xULN",
                                "criterion": "ALT",
                                "requirement": {
                                    "requirement_type": "quantity",
                                    "expected_value": {
                                        "operator": "<=",
                                        "value": 3,
                                        "unit": "x ULN"
                                    }
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Presence of a cytopenia for >30 days. Cytopenia will be defined using accepted CHRS (Clonal Hematopoiesis Risk Score) criteria (Weeks et al, NEJM Evidence in press): ANC <1.8 or hgb <12 in females and <13 in males or a platelet count of <150.",
                "criterions": [
                    {
                        "exact_snippets": "Presence of a cytopenia for >30 days",
                        "criterion": "cytopenia",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Presence of a cytopenia for >30 days",
                        "criterion": "cytopenia",
                        "requirement": {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">",
                                "value": 30,
                                "unit": "days"
                            }
                        }
                    },
                    {
                        "exact_snippets": "ANC <1.8",
                        "criterion": "absolute neutrophil count (ANC)",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 1.8,
                                "unit": ""
                            }
                        }
                    },
                    {
                        "exact_snippets": "hgb <12 in females",
                        "criterion": "hemoglobin (hgb) in females",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 12,
                                "unit": ""
                            }
                        }
                    },
                    {
                        "exact_snippets": "hgb <13 in males",
                        "criterion": "hemoglobin (hgb) in males",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 13,
                                "unit": ""
                            }
                        }
                    },
                    {
                        "exact_snippets": "platelet count of <150",
                        "criterion": "platelet count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 150,
                                "unit": ""
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Presence of a cytopenia for >30 days",
                                "criterion": "cytopenia",
                                "requirement": {
                                    "requirement_type": "presence",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "Presence of a cytopenia for >30 days",
                                "criterion": "cytopenia",
                                "requirement": {
                                    "requirement_type": "duration",
                                    "expected_value": {
                                        "operator": ">",
                                        "value": 30,
                                        "unit": "days"
                                    }
                                }
                            }
                        ]
                    },
                    {
                        "or_criteria": [
                            {
                                "exact_snippets": "ANC <1.8",
                                "criterion": "absolute neutrophil count (ANC)",
                                "requirement": {
                                    "requirement_type": "quantity",
                                    "expected_value": {
                                        "operator": "<",
                                        "value": 1.8,
                                        "unit": ""
                                    }
                                }
                            },
                            {
                                "exact_snippets": "hgb <12 in females",
                                "criterion": "hemoglobin (hgb) in females",
                                "requirement": {
                                    "requirement_type": "quantity",
                                    "expected_value": {
                                        "operator": "<",
                                        "value": 12,
                                        "unit": ""
                                    }
                                }
                            },
                            {
                                "exact_snippets": "hgb <13 in males",
                                "criterion": "hemoglobin (hgb) in males",
                                "requirement": {
                                    "requirement_type": "quantity",
                                    "expected_value": {
                                        "operator": "<",
                                        "value": 13,
                                        "unit": ""
                                    }
                                }
                            },
                            {
                                "exact_snippets": "platelet count of <150",
                                "criterion": "platelet count",
                                "requirement": {
                                    "requirement_type": "quantity",
                                    "expected_value": {
                                        "operator": "<",
                                        "value": 150,
                                        "unit": ""
                                    }
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Age ≥ 18 years as MDS and CCUS are very rare conditions in the pediatric setting.",
                "criterions": [
                    {
                        "exact_snippets": "Age ≥ 18 years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum age",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Age ≥ 18 years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum age",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Presence of a somatic pathogenic variant associated with hematological malignancy without morphological evidence of myelodysplasia",
                "criterions": [
                    {
                        "exact_snippets": "Presence of a somatic pathogenic variant associated with hematological malignancy",
                        "criterion": "somatic pathogenic variant associated with hematological malignancy",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "without morphological evidence of myelodysplasia",
                        "criterion": "morphological evidence of myelodysplasia",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Presence of a somatic pathogenic variant associated with hematological malignancy",
                        "criterion": "somatic pathogenic variant associated with hematological malignancy",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "without morphological evidence of myelodysplasia",
                        "criterion": "morphological evidence of myelodysplasia",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* ECOG performance status </=2.",
                "criterions": [
                    {
                        "exact_snippets": "ECOG performance status </=2",
                        "criterion": "ECOG performance status",
                        "requirement": {
                            "requirement_type": "score",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": ""
                                    }
                                ]
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "ECOG performance status </=2",
                        "criterion": "ECOG performance status",
                        "requirement": {
                            "requirement_type": "score",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": ""
                                    }
                                ]
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Healthy volunteers allowed",
                "criterions": [
                    {
                        "exact_snippets": "Healthy volunteers allowed",
                        "criterion": "healthy volunteer status",
                        "requirement": {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Healthy volunteers allowed",
                        "criterion": "healthy volunteer status",
                        "requirement": {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Cohort 1: Hemoglobin <10g/dL with symptomatic anemia or transfusion dependency defined as the need for prior transfusion in the past 8 weeks for a hemoglobin level less than 8g/dl.",
                "criterions": [
                    {
                        "exact_snippets": "Hemoglobin <10g/dL",
                        "criterion": "hemoglobin level",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 10,
                                "unit": "g/dL"
                            }
                        }
                    },
                    {
                        "exact_snippets": "symptomatic anemia",
                        "criterion": "anemia symptoms",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "transfusion dependency defined as the need for prior transfusion in the past 8 weeks for a hemoglobin level less than 8g/dl",
                        "criterion": "transfusion dependency",
                        "requirement": {
                            "requirement_type": "prior transfusion",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "in past 8 weeks"
                            }
                        }
                    },
                    {
                        "exact_snippets": "transfusion dependency defined as the need for prior transfusion in the past 8 weeks for a hemoglobin level less than 8g/dl",
                        "criterion": "transfusion dependency",
                        "requirement": {
                            "requirement_type": "hemoglobin level at transfusion",
                            "expected_value": {
                                "operator": "<",
                                "value": 8,
                                "unit": "g/dL"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Hemoglobin <10g/dL",
                                "criterion": "hemoglobin level",
                                "requirement": {
                                    "requirement_type": "quantity",
                                    "expected_value": {
                                        "operator": "<",
                                        "value": 10,
                                        "unit": "g/dL"
                                    }
                                }
                            },
                            {
                                "or_criteria": [
                                    {
                                        "exact_snippets": "symptomatic anemia",
                                        "criterion": "anemia symptoms",
                                        "requirement": {
                                            "requirement_type": "presence",
                                            "expected_value": true
                                        }
                                    },
                                    {
                                        "and_criteria": [
                                            {
                                                "exact_snippets": "transfusion dependency defined as the need for prior transfusion in the past 8 weeks for a hemoglobin level less than 8g/dl",
                                                "criterion": "transfusion dependency",
                                                "requirement": {
                                                    "requirement_type": "prior transfusion",
                                                    "expected_value": {
                                                        "operator": ">=",
                                                        "value": 1,
                                                        "unit": "in past 8 weeks"
                                                    }
                                                }
                                            },
                                            {
                                                "exact_snippets": "transfusion dependency defined as the need for prior transfusion in the past 8 weeks for a hemoglobin level less than 8g/dl",
                                                "criterion": "transfusion dependency",
                                                "requirement": {
                                                    "requirement_type": "hemoglobin level at transfusion",
                                                    "expected_value": {
                                                        "operator": "<",
                                                        "value": 8,
                                                        "unit": "g/dL"
                                                    }
                                                }
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Cohort 4: Diagnosis of CCUS defined as:",
                "criterions": [
                    {
                        "exact_snippets": "Diagnosis of CCUS",
                        "criterion": "CCUS diagnosis",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Diagnosis of CCUS",
                        "criterion": "CCUS diagnosis",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Variant allele fraction of greater than or equal to 2% in at least one identified somatic pathogenic variant",
                "criterions": [
                    {
                        "exact_snippets": "Variant allele fraction of greater than or equal to 2% in at least one identified somatic pathogenic variant",
                        "criterion": "variant allele fraction in somatic pathogenic variant",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "%"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Variant allele fraction of greater than or equal to 2% in at least one identified somatic pathogenic variant",
                        "criterion": "variant allele fraction in somatic pathogenic variant",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "%"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Must have minimum age of 18 Years",
                "criterions": [
                    {
                        "exact_snippets": "minimum age of 18 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "minimum age of 18 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Cohort 2: Transfusion dependency defined as the need for prior transfusion in the past 8 weeks of (1) at least 2 units of PRBC for a hemoglobin level less than 8g/dl or symptomatic anemia (hemoglobin <10g/dL), or (2) any platelet transfusion.",
                "criterions": [
                    {
                        "exact_snippets": "need for prior transfusion in the past 8 weeks",
                        "criterion": "transfusion dependency",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "need for prior transfusion in the past 8 weeks",
                        "criterion": "transfusion dependency",
                        "requirement": {
                            "requirement_type": "time frame",
                            "expected_value": "past 8 weeks"
                        }
                    },
                    {
                        "exact_snippets": "at least 2 units of PRBC for a hemoglobin level less than 8g/dl",
                        "criterion": "PRBC transfusion",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "units"
                            }
                        }
                    },
                    {
                        "exact_snippets": "at least 2 units of PRBC for a hemoglobin level less than 8g/dl",
                        "criterion": "PRBC transfusion",
                        "requirement": {
                            "requirement_type": "hemoglobin level",
                            "expected_value": {
                                "operator": "<",
                                "value": 8,
                                "unit": "g/dl"
                            }
                        }
                    },
                    {
                        "exact_snippets": "symptomatic anemia (hemoglobin <10g/dL)",
                        "criterion": "symptomatic anemia",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "symptomatic anemia (hemoglobin <10g/dL)",
                        "criterion": "symptomatic anemia",
                        "requirement": {
                            "requirement_type": "hemoglobin level",
                            "expected_value": {
                                "operator": "<",
                                "value": 10,
                                "unit": "g/dL"
                            }
                        }
                    },
                    {
                        "exact_snippets": "any platelet transfusion",
                        "criterion": "platelet transfusion",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "need for prior transfusion in the past 8 weeks",
                                "criterion": "transfusion dependency",
                                "requirement": {
                                    "requirement_type": "presence",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "need for prior transfusion in the past 8 weeks",
                                "criterion": "transfusion dependency",
                                "requirement": {
                                    "requirement_type": "time frame",
                                    "expected_value": "past 8 weeks"
                                }
                            }
                        ]
                    },
                    {
                        "or_criteria": [
                            {
                                "and_criteria": [
                                    {
                                        "exact_snippets": "at least 2 units of PRBC for a hemoglobin level less than 8g/dl",
                                        "criterion": "PRBC transfusion",
                                        "requirement": {
                                            "requirement_type": "quantity",
                                            "expected_value": {
                                                "operator": ">=",
                                                "value": 2,
                                                "unit": "units"
                                            }
                                        }
                                    },
                                    {
                                        "exact_snippets": "at least 2 units of PRBC for a hemoglobin level less than 8g/dl",
                                        "criterion": "PRBC transfusion",
                                        "requirement": {
                                            "requirement_type": "hemoglobin level",
                                            "expected_value": {
                                                "operator": "<",
                                                "value": 8,
                                                "unit": "g/dl"
                                            }
                                        }
                                    }
                                ]
                            },
                            {
                                "and_criteria": [
                                    {
                                        "exact_snippets": "symptomatic anemia (hemoglobin <10g/dL)",
                                        "criterion": "symptomatic anemia",
                                        "requirement": {
                                            "requirement_type": "presence",
                                            "expected_value": true
                                        }
                                    },
                                    {
                                        "exact_snippets": "symptomatic anemia (hemoglobin <10g/dL)",
                                        "criterion": "symptomatic anemia",
                                        "requirement": {
                                            "requirement_type": "hemoglobin level",
                                            "expected_value": {
                                                "operator": "<",
                                                "value": 10,
                                                "unit": "g/dL"
                                            }
                                        }
                                    }
                                ]
                            },
                            {
                                "exact_snippets": "any platelet transfusion",
                                "criterion": "platelet transfusion",
                                "requirement": {
                                    "requirement_type": "presence",
                                    "expected_value": true
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Participants (or patient's legally authorized representative) must have signed an informed consent document indicating that the patient understands the purpose of and procedures required for the study and is willing to participate in the study.",
                "criterions": [
                    {
                        "exact_snippets": "Participants (or patient's legally authorized representative) must have signed an informed consent document",
                        "criterion": "informed consent document",
                        "requirement": {
                            "requirement_type": "signed",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "indicating that the patient understands the purpose of and procedures required for the study",
                        "criterion": "understanding of study purpose and procedures",
                        "requirement": {
                            "requirement_type": "understanding",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "is willing to participate in the study",
                        "criterion": "willingness to participate",
                        "requirement": {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Participants (or patient's legally authorized representative) must have signed an informed consent document",
                        "criterion": "informed consent document",
                        "requirement": {
                            "requirement_type": "signed",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "indicating that the patient understands the purpose of and procedures required for the study",
                        "criterion": "understanding of study purpose and procedures",
                        "requirement": {
                            "requirement_type": "understanding",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "is willing to participate in the study",
                        "criterion": "willingness to participate",
                        "requirement": {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    }
                ]
            }
        }
    ],
    "exclusion_lines": [
        {
            "identified_line": {
                "line": "* Female participants who are pregnant or lactating.",
                "criterions": [
                    {
                        "exact_snippets": "Female participants",
                        "criterion": "sex",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": "female"
                        }
                    },
                    {
                        "exact_snippets": "pregnant",
                        "criterion": "pregnancy status",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "lactating",
                        "criterion": "lactation status",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Female participants",
                                "criterion": "sex",
                                "requirement": {
                                    "requirement_type": "value",
                                    "expected_value": "female"
                                }
                            },
                            {
                                "exact_snippets": "pregnant",
                                "criterion": "pregnancy status",
                                "requirement": {
                                    "requirement_type": "presence",
                                    "expected_value": true
                                }
                            }
                        ]
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Female participants",
                                "criterion": "sex",
                                "requirement": {
                                    "requirement_type": "value",
                                    "expected_value": "female"
                                }
                            },
                            {
                                "exact_snippets": "lactating",
                                "criterion": "lactation status",
                                "requirement": {
                                    "requirement_type": "presence",
                                    "expected_value": true
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Prior treatment with IL-1/IL-1r inhibitors",
                "criterions": [
                    {
                        "exact_snippets": "Prior treatment with IL-1/IL-1r inhibitors",
                        "criterion": "prior treatment with IL-1/IL-1r inhibitors",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "not_criteria": {
                    "exact_snippets": "Prior treatment with IL-1/IL-1r inhibitors",
                    "criterion": "prior treatment with IL-1/IL-1r inhibitors",
                    "requirement": {
                        "requirement_type": "history",
                        "expected_value": true
                    }
                }
            }
        },
        {
            "identified_line": {
                "line": "* Active infection not adequately responding to appropriate antibiotics.",
                "criterions": [
                    {
                        "exact_snippets": "Active infection not adequately responding to appropriate antibiotics",
                        "criterion": "active infection",
                        "requirement": {
                            "requirement_type": "response to antibiotics",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Active infection not adequately responding to appropriate antibiotics",
                        "criterion": "active infection",
                        "requirement": {
                            "requirement_type": "response to antibiotics",
                            "expected_value": false
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Known history of testing positive for Human Immunodeficiency Virus (HIV) infections.",
                "criterions": [
                    {
                        "exact_snippets": "Known history of testing positive for Human Immunodeficiency Virus (HIV) infections",
                        "criterion": "Human Immunodeficiency Virus (HIV) infection",
                        "requirement": {
                            "requirement_type": "history of positive test",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "not_criteria": {
                    "exact_snippets": "Known history of testing positive for Human Immunodeficiency Virus (HIV) infections",
                    "criterion": "Human Immunodeficiency Virus (HIV) infection",
                    "requirement": {
                        "requirement_type": "history of positive test",
                        "expected_value": true
                    }
                }
            }
        },
        {
            "identified_line": {
                "line": "* Participants receiving any other concurrent investigational agent or chemotherapy, radiotherapy, or immunotherapy (within 14 days of initiating study treatment).",
                "criterions": [
                    {
                        "exact_snippets": "Participants receiving any other concurrent investigational agent",
                        "criterion": "concurrent investigational agent",
                        "requirement": {
                            "requirement_type": "use",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "Participants receiving any other concurrent ... chemotherapy, radiotherapy, or immunotherapy (within 14 days of initiating study treatment)",
                        "criterion": "chemotherapy, radiotherapy, or immunotherapy within 14 days of initiating study treatment",
                        "requirement": {
                            "requirement_type": "use_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 14,
                                "unit": "days"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Participants receiving any other concurrent ... chemotherapy, radiotherapy, or immunotherapy (within 14 days of initiating study treatment)",
                        "criterion": "chemotherapy, radiotherapy, or immunotherapy within 14 days of initiating study treatment",
                        "requirement": {
                            "requirement_type": "use",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Participants receiving any other concurrent investigational agent",
                        "criterion": "concurrent investigational agent",
                        "requirement": {
                            "requirement_type": "use",
                            "expected_value": false
                        }
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Participants receiving any other concurrent ... chemotherapy, radiotherapy, or immunotherapy (within 14 days of initiating study treatment)",
                                "criterion": "chemotherapy, radiotherapy, or immunotherapy within 14 days of initiating study treatment",
                                "requirement": {
                                    "requirement_type": "use_within_timeframe",
                                    "expected_value": {
                                        "operator": "<=",
                                        "value": 14,
                                        "unit": "days"
                                    }
                                }
                            },
                            {
                                "exact_snippets": "Participants receiving any other concurrent ... chemotherapy, radiotherapy, or immunotherapy (within 14 days of initiating study treatment)",
                                "criterion": "chemotherapy, radiotherapy, or immunotherapy within 14 days of initiating study treatment",
                                "requirement": {
                                    "requirement_type": "use",
                                    "expected_value": false
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* History of an active malignancy within the past 2 years prior to study entry, with the exception of: a. Adequately treated in situ carcinoma of the cervix uteri b. Adequately treated basal cell carcinoma or localized squamous cell carcinoma of the skin or any other malignancy with a life expectancy of more than 2 years.",
                "criterions": [
                    {
                        "exact_snippets": "History of an active malignancy within the past 2 years prior to study entry",
                        "criterion": "active malignancy",
                        "requirement": {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "years"
                            }
                        }
                    },
                    {
                        "exact_snippets": "exception of: a. Adequately treated in situ carcinoma of the cervix uteri",
                        "criterion": "in situ carcinoma of the cervix uteri",
                        "requirement": {
                            "requirement_type": "treatment_status",
                            "expected_value": "adequately treated"
                        }
                    },
                    {
                        "exact_snippets": "exception of: b. Adequately treated basal cell carcinoma or localized squamous cell carcinoma of the skin",
                        "criterion": "basal cell carcinoma of the skin",
                        "requirement": {
                            "requirement_type": "treatment_status",
                            "expected_value": "adequately treated"
                        }
                    },
                    {
                        "exact_snippets": "exception of: b. Adequately treated basal cell carcinoma or localized squamous cell carcinoma of the skin",
                        "criterion": "localized squamous cell carcinoma of the skin",
                        "requirement": {
                            "requirement_type": "treatment_status",
                            "expected_value": "adequately treated"
                        }
                    },
                    {
                        "exact_snippets": "any other malignancy with a life expectancy of more than 2 years",
                        "criterion": "other malignancy",
                        "requirement": {
                            "requirement_type": "life_expectancy",
                            "expected_value": {
                                "operator": ">",
                                "value": 2,
                                "unit": "years"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "not_criteria": {
                            "or_criteria": [
                                {
                                    "and_criteria": [
                                        {
                                            "exact_snippets": "History of an active malignancy within the past 2 years prior to study entry",
                                            "criterion": "active malignancy",
                                            "requirement": {
                                                "requirement_type": "history_within_timeframe",
                                                "expected_value": {
                                                    "operator": "<=",
                                                    "value": 2,
                                                    "unit": "years"
                                                }
                                            }
                                        },
                                        {
                                            "not_criteria": {
                                                "or_criteria": [
                                                    {
                                                        "exact_snippets": "exception of: a. Adequately treated in situ carcinoma of the cervix uteri",
                                                        "criterion": "in situ carcinoma of the cervix uteri",
                                                        "requirement": {
                                                            "requirement_type": "treatment_status",
                                                            "expected_value": "adequately treated"
                                                        }
                                                    },
                                                    {
                                                        "exact_snippets": "exception of: b. Adequately treated basal cell carcinoma or localized squamous cell carcinoma of the skin",
                                                        "criterion": "basal cell carcinoma of the skin",
                                                        "requirement": {
                                                            "requirement_type": "treatment_status",
                                                            "expected_value": "adequately treated"
                                                        }
                                                    },
                                                    {
                                                        "exact_snippets": "exception of: b. Adequately treated basal cell carcinoma or localized squamous cell carcinoma of the skin",
                                                        "criterion": "localized squamous cell carcinoma of the skin",
                                                        "requirement": {
                                                            "requirement_type": "treatment_status",
                                                            "expected_value": "adequately treated"
                                                        }
                                                    },
                                                    {
                                                        "exact_snippets": "any other malignancy with a life expectancy of more than 2 years",
                                                        "criterion": "other malignancy",
                                                        "requirement": {
                                                            "requirement_type": "life_expectancy",
                                                            "expected_value": {
                                                                "operator": ">",
                                                                "value": 2,
                                                                "unit": "years"
                                                            }
                                                        }
                                                    }
                                                ]
                                            }
                                        }
                                    ]
                                }
                            ]
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Absolute neutrophil count (ANC) <0.5x109 k/ul; colony-stimulating factors can be administered prior to study drug initiation.",
                "criterions": [
                    {
                        "exact_snippets": "Absolute neutrophil count (ANC) <0.5x109 k/ul",
                        "criterion": "absolute neutrophil count (ANC)",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 0.5,
                                "unit": "x10^9 k/ul"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Absolute neutrophil count (ANC) <0.5x109 k/ul",
                        "criterion": "absolute neutrophil count (ANC)",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 0.5,
                                "unit": "x10^9 k/ul"
                            }
                        }
                    }
                ]
            }
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "identified_line": {
                "line": "* Cohort 1: Participants need to have not responded to prior therapy with ESAs or hypomethylating agents (HMAs). These could include azacitidine, decitabine, SGI-110, ASTX727, or CC-486. Patients will need to have received at least 4 cycles of HMA. Participants with relapse or progression after any number of cycles of HMA by IWG 2006 criteria will also be candidates. Participants with evidence of del 5q alteration also are required to have been treated with Lenalidomide.",
                "criterions": [
                    {
                        "exact_snippets": "Participants need to have not responded to prior therapy with ESAs or hypomethylating agents (HMAs)",
                        "criterion": "response to prior therapy with ESAs or HMAs",
                        "requirement": {
                            "requirement_type": "response",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "Patients will need to have received at least 4 cycles of HMA",
                        "criterion": "number of HMA cycles received",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 4,
                                "unit": "cycles"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Participants with relapse or progression after any number of cycles of HMA by IWG 2006 criteria will also be candidates",
                        "criterion": "relapse or progression after HMA by IWG 2006 criteria",
                        "requirement": {
                            "requirement_type": "status",
                            "expected_value": [
                                "relapse",
                                "progression"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "Participants with evidence of del 5q alteration also are required to have been treated with Lenalidomide",
                        "criterion": "treatment with Lenalidomide in participants with del 5q alteration",
                        "requirement": {
                            "requirement_type": "del 5q alteration",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Participants with evidence of del 5q alteration also are required to have been treated with Lenalidomide",
                        "criterion": "treatment with Lenalidomide in participants with del 5q alteration",
                        "requirement": {
                            "requirement_type": "treatment with Lenalidomide",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "* Cohorts 1-3: Diagnosis of MDS according to WHO 2016 classification and low or intermediate-1 risk by IPSS or IPSS-R with a score of ≤ 3.5.",
                "criterions": [
                    {
                        "exact_snippets": "Diagnosis of MDS according to WHO 2016 classification",
                        "criterion": "myelodysplastic syndrome (MDS) diagnosis",
                        "requirement": {
                            "requirement_type": "diagnosis",
                            "expected_value": "MDS according to WHO 2016 classification"
                        }
                    },
                    {
                        "exact_snippets": "low or intermediate-1 risk by IPSS or IPSS-R",
                        "criterion": "MDS risk category by IPSS or IPSS-R",
                        "requirement": {
                            "requirement_type": "risk category",
                            "expected_value": [
                                "low",
                                "intermediate-1"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "score of ≤ 3.5",
                        "criterion": "IPSS or IPSS-R score",
                        "requirement": {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3.5,
                                "unit": ""
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        }
    ],
    "failed_exclusion": [
        {
            "identified_line": {
                "line": "* Female participants with reproductive potential who do not have a negative urine or blood beta-human chorionic gonadotropin (beta HCG) pregnancy test at screening.",
                "criterions": [
                    {
                        "exact_snippets": "Female participants with reproductive potential",
                        "criterion": "sex and reproductive potential",
                        "requirement": {
                            "requirement_type": "sex",
                            "expected_value": "female"
                        }
                    },
                    {
                        "exact_snippets": "Female participants with reproductive potential",
                        "criterion": "sex and reproductive potential",
                        "requirement": {
                            "requirement_type": "reproductive potential",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "do not have a negative urine or blood beta-human chorionic gonadotropin (beta HCG) pregnancy test at screening",
                        "criterion": "pregnancy test result at screening",
                        "requirement": {
                            "requirement_type": "test type",
                            "expected_value": [
                                "urine beta HCG",
                                "blood beta HCG"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "do not have a negative urine or blood beta-human chorionic gonadotropin (beta HCG) pregnancy test at screening",
                        "criterion": "pregnancy test result at screening",
                        "requirement": {
                            "requirement_type": "result",
                            "expected_value": "not negative"
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "Participants requiring systemic steroids, methotrexate or other immunosuppressive drugs will not be included in the study.",
                "criterions": [
                    {
                        "exact_snippets": "requiring systemic steroids",
                        "criterion": "systemic steroid use",
                        "requirement": {
                            "requirement_type": "use",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "requiring ... methotrexate",
                        "criterion": "methotrexate use",
                        "requirement": {
                            "requirement_type": "use",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "requiring ... other immunosuppressive drugs",
                        "criterion": "immunosuppressive drug use (other than steroids or methotrexate)",
                        "requirement": {
                            "requirement_type": "use",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "requiring systemic steroids",
                        "criterion": "systemic steroid use",
                        "requirement": {
                            "requirement_type": "use",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "requiring ... methotrexate",
                        "criterion": "methotrexate use",
                        "requirement": {
                            "requirement_type": "use",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "requiring ... other immunosuppressive drugs",
                        "criterion": "immunosuppressive drug use (other than steroids or methotrexate)",
                        "requirement": {
                            "requirement_type": "use",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Participants with reproductive potential who are unwilling to following contraception requirements (including condom use for males with sexual partners, and for females: prescription oral contraceptives [birth control pills], contraceptive injections, intrauterine devices [IUD], double-barrier method [spermicidal jelly or foam with condoms or diaphragm], contraceptive patch, or surgical sterilization) throughout the study. Reproductive potential is defined as no previous surgical sterilization or females that are not post-menopausal for 12 months.",
                "criterions": [
                    {
                        "exact_snippets": "Participants with reproductive potential",
                        "criterion": "reproductive potential",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "unwilling to following contraception requirements (including condom use for males with sexual partners, and for females: prescription oral contraceptives [birth control pills], contraceptive injections, intrauterine devices [IUD], double-barrier method [spermicidal jelly or foam with condoms or diaphragm], contraceptive patch, or surgical sterilization) throughout the study",
                        "criterion": "contraception use",
                        "requirement": {
                            "requirement_type": "willingness to use contraception",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "unwilling to following contraception requirements (including condom use for males with sexual partners, and for females: prescription oral contraceptives [birth control pills], contraceptive injections, intrauterine devices [IUD], double-barrier method [spermicidal jelly or foam with condoms or diaphragm], contraceptive patch, or surgical sterilization) throughout the study",
                        "criterion": "contraception use",
                        "requirement": {
                            "requirement_type": "contraception methods",
                            "expected_value": [
                                "condom use for males with sexual partners",
                                "prescription oral contraceptives",
                                "contraceptive injections",
                                "intrauterine devices",
                                "double-barrier method",
                                "contraceptive patch",
                                "surgical sterilization"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "unwilling to following contraception requirements (including condom use for males with sexual partners, and for females: prescription oral contraceptives [birth control pills], contraceptive injections, intrauterine devices [IUD], double-barrier method [spermicidal jelly or foam with condoms or diaphragm], contraceptive patch, or surgical sterilization) throughout the study",
                        "criterion": "contraception use",
                        "requirement": {
                            "requirement_type": "duration",
                            "expected_value": "throughout the study"
                        }
                    },
                    {
                        "exact_snippets": "Reproductive potential is defined as no previous surgical sterilization or females that are not post-menopausal for 12 months",
                        "criterion": "surgical sterilization",
                        "requirement": {
                            "requirement_type": "history of surgical sterilization",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "females that are not post-menopausal for 12 months",
                        "criterion": "menopausal status",
                        "requirement": {
                            "requirement_type": "post-menopausal duration",
                            "expected_value": {
                                "operator": "<",
                                "value": 12,
                                "unit": "months"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        }
    ],
    "failed_miscellaneous": []
}